Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
about
Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniquesPrognostic significance of volume-based PET parameters in cancer patients.Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancersImage-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model.Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationContemporary Diagnostic Imaging of Oral Squamous Cell Carcinoma - A Review of Literature.Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy.Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study.Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.Quantification of heterogeneity as a biomarker in tumor imaging: a systematic reviewIn Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRIMagnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomicsEvaluation of Head and Neck Tumors with Functional MR Imaging.PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerCurrent oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer.Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neckPretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.Quantitative multimodality imaging in cancer research and therapyThe Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.Multimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience.Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy.Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma.Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.Characterization of cervical lymph nodes using DCE-MRI: Differentiation between metastases from SCC of head and neck and benign lymph nodes.Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma.Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Imaging technologies from bench to bedside.Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Regional Nodal Metastasis in Nasopharyngeal Carcinoma: Correlation with Nodal Staging.Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ i ): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas.
P2860
Q26828595-F702654F-BFE3-4415-9D2E-C740FDE3B787Q27687836-F2905362-4704-4084-B2A2-26C9B07B35E3Q28075983-E246A7AE-3B5A-4970-93A2-40907025B28CQ30456019-AF318DD5-5801-4E5A-BBE9-4693673D1B1DQ30575110-60F63E95-BA52-4FA5-8219-052571D5487AQ33565054-1764148A-3F71-49AC-A368-B0D30FC6622CQ34172445-437833BD-808C-400F-AB49-68846062455CQ34757933-0CF81FEF-E363-4939-88DB-04AE69184A46Q34777812-0746DA16-1325-4FEA-894B-2502D00912B6Q34951384-C143DAB6-8EEF-4213-9A72-73152B2912F9Q35015049-636702B9-6EC1-4EA3-A9C0-B0D216E12EECQ35219168-481EC02E-2C5E-4215-AC8C-AD4595D16EA6Q35275024-7969634F-1AAB-4CB4-AEE7-D6956B1B5701Q35350679-271B5456-DF62-4E88-AC97-7CAA96C25377Q35744865-03AA5670-91BC-44D8-A887-C6FD4EA4B193Q36174425-A7D9897B-87AB-4035-BC94-C99F9B60F8FAQ36330208-DD3A283F-B4C1-48E5-ACAD-055D1AA354E6Q36357752-71D05DF8-16C7-4F6D-9A8A-54219CC23581Q36515722-2E419D98-D74A-45C8-8D89-99F6B939FF2EQ36529838-19803531-694F-4201-8DF2-7CC8379844F3Q36536973-3140AEC8-75F1-4BD6-A942-2B4455505F46Q36547400-4A81365C-57BB-4916-9D6F-C8D120B0E75BQ36580841-0144C706-A191-41D8-A984-A5958316BAF2Q36910794-BF27602D-F073-4FCA-85BA-0D6639F535B6Q37007810-DA9E7C7E-CF2D-486F-87EC-A6DAC969B0F2Q37328698-09B4A254-C28F-48BE-8811-80B6A3B46C00Q37590957-5A28D541-60E0-41C2-9AFD-6975F84C8109Q37644820-1DF464FD-4A8B-4A75-8C13-BD07097EA059Q38424780-6EB6172C-6EDF-448B-8BBD-4CECEA646B35Q38597048-C389FCAD-715C-43DC-8372-ECF729164BEFQ38685910-B79645EF-7824-45EB-B85B-2A9A67F37D97Q38729555-ACA55E88-A986-4459-B76C-84E295060918Q38830809-F03887BA-4BFD-4923-B9A7-F7D8E6BCEAEFQ40720743-10FD29CA-EF4F-40E7-ACFA-37D68F65C4A5Q40890024-1D11CEBD-BE8D-4DEC-B303-942BE826A26FQ41919665-BD29B6BA-A335-4A48-94CE-03363BA1BCAAQ42365356-06FFF84A-5381-4690-9019-063D137B08F2Q42691434-B147EC71-CD38-4DED-8301-CA2812A4BBF1Q43376048-6DED58BB-9652-46A2-8EBF-20104219DA66Q47793448-160AEAAC-A762-4B19-BBB0-A392827C41CD
P2860
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@ast
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@en
type
label
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@ast
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@en
prefLabel
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@ast
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@en
P2093
P2860
P1476
Tumor metabolism and perfusion ...... nhanced MRI, and [18F]FDG-PET.
@en
P2093
Amita Shukla-Dave
David G Pfister
Heiko Schöder
Hilda E Stambuk
Jacobus F A Jansen
Jason A Koutcher
Jatin P Shah
Matthew G Fury
Nancy Y Lee
Snehal G Patel
P2860
P304
P356
10.1016/J.IJROBP.2010.11.022
P407
P577
2011-01-13T00:00:00Z